Table of Contents Author Guidelines Submit a Manuscript
Erratum

An erratum for this article has been published. To view the erratum, please click here.

Clinical and Developmental Immunology
Volume 2010, Article ID 504979, 9 pages
http://dx.doi.org/10.1155/2010/504979
Clinical Study

Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis

1Immunotherapy Unit, Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), 47014 Meldola, Italy
2Unit of Biostatistics and Clinical Trials, Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), 47014 Meldola, Italy
3Blood Transfusion Unit, Morgagni-Pierantoni Hospital, 47100 Forlì, Italy
4Thoracic Surgery Unit, Morgagni-Pierantoni Hospital, 47100 Forlì, Italy
5Advanced Oncological Surgery Unit, Morgagni-Pierantoni Hospital, 47100 Forlì, Italy

Received 22 June 2010; Accepted 13 August 2010

Academic Editor: Bernhard Fleischer

Copyright © 2010 Laura Ridolfi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Laura Ridolfi, Massimiliano Petrini, Laura Fiammenghi, et al., “Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis,” Clinical and Developmental Immunology, vol. 2010, Article ID 504979, 9 pages, 2010. https://doi.org/10.1155/2010/504979.